{"schema_version":"secwatch.filing_event.v1","accession":"0001872789-24-000031","form_type":"8-K","ticker":"EMBC","cik":"0001872789","company_name":"Embecta Corp.","filed_at":"2024-11-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.206232+00:00","generated_at":"2026-05-29T18:09:47.920239+00:00","sec_items":["2.02","2.05","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Embecta Q4 beats; discontinues patch pump; restructuring saves $60-65M annually; FY2025 EPS guidance $2.70-2.90","bullets":["Q4 reported rev $286.1M (+1.5%), GAAP EPS $0.25, adjusted EPS $0.45.","FY2024 rev $1,123.1M (+0.2%), adjusted EPS $2.45, GAAP EPS $1.34.","Discontinues insulin patch pump; expects $35-45M pre-tax charges in FY2025; annualized savings $60-65M.","FY2025 guidance: rev $1,093-1,110M, adjusted EPS $2.70-2.90, adj. EBITDA margin 35.5-36.5%.","Board declares $0.15/share dividend payable Dec 18, 2024 to holders of record Dec 6, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001872789-24-000031","json":"https://secwatch.observer/filing/0001872789-24-000031.json","markdown":"https://secwatch.observer/filing/0001872789-24-000031.md","text":"https://secwatch.observer/filing/0001872789-24-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872789/000187278924000031/0001872789-24-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872789/000187278924000031/embc-20241126.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T18:09:47.920239+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}